Zaloguj się

Gotowe bibliografie tematyczne / Coronary heart disease / Artykuły w czasopismach

Artykuły w czasopismach na temat „Coronary heart disease”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Coronary heart disease.

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 29 lipca 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Coronary heart disease”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Nurmamadovna, Ishankulova Nasiba. "Coronary Heart Disease". American Journal of Medical Sciences and Pharmaceutical Research 03, nr 02 (28.02.2021): 31–36. http://dx.doi.org/10.37547/tajmspr/volume03issue02-04.

Pełny tekst źródła

Streszczenie:

The article covers the etiology, pathogenesis, classification, diagnosis, clinical picture and treatment of coronary heart disease, provides a literature review. Cardiovascular disease (CVD) represents the leading cause of death among women as well as men. The number of deaths due to CVD in women are greater than in men. There are significant gender-related differences concerning CVD.

Style APA, Harvard, Vancouver, ISO itp.

2

Shakhnoza, Iskandarova, i Amilova Asalya. "PREVENTION OF CORONARY HEART DISEASE". American Journal of Medical Sciences and Pharmaceutical Research 04, nr 04 (1.04.2022): 19–21. http://dx.doi.org/10.37547/tajmspr/volume04issue04-05.

Pełny tekst źródła

Streszczenie:

Primary prevention, based on healthy lifestyle habits that prevent the emergence of risk factors, is the preferred method of reducing cardiovascular risk. Reducing the prevalence of obesity is the most urgent task, and it is pleiotropic in that it affects blood pressure, lipid profile, glucose metabolism, inflammation, progression of atherothrombotic disease. Physical activity also improves several risk factors, with the added potential to lower heart rate.

Style APA, Harvard, Vancouver, ISO itp.

3

Sudhakar, B. G. K. "Structural heart disease interventions". Clinical Research and Clinical Trials 3, nr 5 (25.06.2021): 01–05. http://dx.doi.org/10.31579/2693-4779/042.

Pełny tekst źródła

Streszczenie:

Seed for invasive cardiology was sown in early part of nineties. Cardiac catheterization was actually pioneered by Werner Forssmann in 1929. However, credit for therapeutic interventional cardiology should go to US vascular radiologist, Charles Theodore Dotter for performing first peripheral arterial angioplasty [PTA] in 1964. Subsequently, a German cardiologist by name Andreas Gruentzig adapted the technique in 1974 to suit coronary artery disease and performed the first human coronary balloon angioplasty to treat blockage in coronary artery in 1977.

Style APA, Harvard, Vancouver, ISO itp.

4

Windecker, S. "CORONARY DISEASE: Intervention in coronary artery disease". Heart 83, nr 4 (1.04.2000): 481–90. http://dx.doi.org/10.1136/heart.83.4.481.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Gulnara, Asadova, i Djamalov Abdurakhman. "REMEDIES AND RECOMMENDATIONS CORONARY HEART DISEASES". Eurasian Journal of Medical and Natural Sciences 03, nr 02 (1.02.2023): 224–28. http://dx.doi.org/10.37547/ejmns-v03-i02-p1-37.

Pełny tekst źródła

Streszczenie:

Prevention of coronary heart disease is a series of complex measures aimed at preventing the onset of the disease, the development and occurrence of possible (predictable) complications, which can be even fatal. Prevention of coronary heart disease is indicated for both sick people and healthy people who are at risk of developing the disease. Patients diagnosed with coronary heart disease are shown non-drug treatment, which is a complete or partial elimination of risk factors. Risk factors are any predisposing factors that increase the likelihood of developing or worsening a disease. Risk factors for coronary heart disease are fundamentally divided into removable and non-removable.

Style APA, Harvard, Vancouver, ISO itp.

6

Jha, Dr Sudha, Dr Naved Ahmad, Dr Surya Kant Nagtilak i Dr Maheshwar Chawla. "Coronary Heart Disease, A Gift of Modern Civilization". International Journal of Scientific Research 2, nr 11 (1.06.2012): 378–80. http://dx.doi.org/10.15373/22778179/nov2013/122.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Timmis, A. "Coronary disease: Acute coronary syndromes: risk stratification". Heart 83, nr 2 (1.02.2000): 241–46. http://dx.doi.org/10.1136/heart.83.2.241.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Gulyabin, Konstantin Robertovich. "Coronary heart disease". Spravočnik vrača obŝej praktiki (Journal of Family Medicine), nr 1 (2022): 63–66. http://dx.doi.org/10.33920/med-10-2201-09.

Pełny tekst źródła

Streszczenie:

Coronary heart disease is of great clinical importance in medical practice. The development of medical science makes it possible to introduce new modern methods of treating this disease. One of these is coronary artery bypass grafting, a modern method of treating coronary heart disease, which allows to reliably increase myocardial perfusion and prolong the life expectancy of patients with coronary heart disease.

Style APA, Harvard, Vancouver, ISO itp.

9

Lavie, Carl J., Gary Legwold i Michael E. DeBakey. "Coronary heart disease". Postgraduate Medicine 102, nr 2 (sierpień 1997): 210–15. http://dx.doi.org/10.3810/pgm.1997.08.285.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Williams, Samantha. "Coronary heart disease". Nursing Standard 19, nr 51 (31.08.2005): 67–68. http://dx.doi.org/10.7748/ns.19.51.67.s58.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Ahmed, Munir. "CORONARY HEART DISEASE;". Professional Medical Journal 21, nr 06 (10.12.2014): 1171–73. http://dx.doi.org/10.29309/tpmj/2014.21.06.2250.

Pełny tekst źródła

Streszczenie:

Objective: This study was done to find any correlation among total cholesterol, triglycerides, low density lipoprotein cholesterol and high density lipoprotein cholesterol estimated in serum of offsprings of coronary heart disease patients. Study Design: A cross sectional comparative study. Patients and Methods: Two hundred and fifty (250) subjects having parents with coronary heart disease were selected from Punjab Institute of Cardiology Lahore. The serum total cholesterol, triglycerides, low density lipoprotein cholesterol, and high density lipoprotein cholesterol were estimated. Coefficient of variation was calculated to find whether observations in one series vary correspondingly with observations in another series. Results: Highly significant positive correlation was found between total cholesterol and triglycerides, and, total cholesterol and low density lipoprotein cholesterol. Highly significant negative correlation was found between low density lipoprotein cholesterol and high density lipoprotein cholesterol. Correlation between TG and LDL-c was also significant. Conclusions: Serum total cholesterol, triglycerides, low density lipoprotein cholesterol and high density lipoprotein cholesterol have strong association with one and other. For prediction, prevention and management of coronary heart disease it is important to estimate and observe the correlation among these parameters.

Style APA, Harvard, Vancouver, ISO itp.

12

AHMED, MUNIR, i MOHAMMAD TAYYIB. "CORONARY HEART DISEASE". Professional Medical Journal 16, nr 01 (10.03.2009): 87–93. http://dx.doi.org/10.29309/tpmj/2009.16.01.2988.

Pełny tekst źródła

Streszczenie:

O b j e c t i v e s : This study was conducted to perform serum lipid profile in off springs of premature coronary heart disease(CHD) patients and age and sex matched normal controls and compare the results of two groups. S t u d y d e s i g n : A cross sectional study.Patients a n d m e t h o d s : 250 off springs of diagnosed premature CHD patients were selected from Punjab institute of cardiology, Lahoreand Services hospital, Lahore. 50 age and sex matched normal controls were selected from different areas of Lahore. Serum totalcholesterol (TC), serum triglycerides (TG) serum low density lipoprotein-cholesterol (LDC-c) and serum high density lipoprotein cholesterol(HDL-c) was performed. Results: Serum TC, TG, LDL-c of off springs of premature CHD patients was increased as compared with normalcontrols. Serum HDL-c of all the subjects of off springs of premature CHD patients was decreased as compared with normal controls.C o n c l u s i o n : Off springs of premature CHD patients are more prone to develop lipid abnormalities as compared with normal controls.

Style APA, Harvard, Vancouver, ISO itp.

13

GILANi, MUHAMMAD SHAH. "CORONARY HEART DISEASE". Professional Medical Journal 15, nr 02 (10.03.2008): 255–59. http://dx.doi.org/10.29309/tpmj/2008.15.02.2759.

Pełny tekst źródła

Streszczenie:

Objective: To assess the value of coronary events reflected by changesin R-wave amplitude after exercise.Setting: Nishtar Hospital, Multan. Duration. One year. Study Design: comparativestudy.Material and Methods: Sample size 146 patients.Sampling Technique: Convenient probability sampling done.Results: All patients were followed up for 6 months, during which time myocardial infarction and death of cardiovascularorigin were considered endpoints. The incidence of events in patients in whom R-wave amplitude decreased (normalresponse) and in those in whom R-wave amplitude did not change or increase (abnormal response) was compared.The incidence of coronary events in patients with a normal response was 23% and in those with an abnormal response,45.8% (p<0.01). Correlating the results with several non invasive and angiographic variables, an abnormal R-waveresponse showed a significantly higher rate of events in the subsets of patients with prior myocardial infarction, absenceof cardiomegaly, maximal functional capacity lower than 4 METs, maximal heart rate higher than 140 beats/min andabnormal left ventricular function. Conclusion: The changes in R-wave amplitude after exercise is a variable thatshould be taken into account when assessing the risk of future events in patients with coronary heart disease.

Style APA, Harvard, Vancouver, ISO itp.

14

Smith, Timothy W., i Arthur S. Leon. "Coronary Heart Disease". Journal of Cardiopulmonary Rehabilitation 14, nr 3 (maj 1994): 201. http://dx.doi.org/10.1097/00008483-199405000-00013.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Emery, Charles F. "Coronary Heart Disease". Journal of Cardiopulmonary Rehabilitation 14, nr 3 (maj 1994): 201. http://dx.doi.org/10.1097/00008483-199405010-00013.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Smith, T. W., A. S. Leon i Robert G. McMurray. "Coronary Heart Disease". Medicine & Science in Sports & Exercise 26, nr 1 (styczeń 1994): 118. http://dx.doi.org/10.1249/00005768-199401000-00023.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Lutz, Wolfgang. "CORONARY HEART DISEASE". Nutrition Today 21, nr 2 (marzec 1986): 40. http://dx.doi.org/10.1097/00017285-198603000-00007.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Ellsworth, DarrellL, Phyliss Sholinsky, Cashell Jaquish, RichardR Fabsitz i TeriA Manolio. "Coronary heart disease:". American Journal of Preventive Medicine 16, nr 2 (luty 1999): 122–33. http://dx.doi.org/10.1016/s0749-3797(98)00138-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Stewart, B. Fendley. "Coronary Heart Disease". Physical Medicine and Rehabilitation Clinics of North America 6, nr 1 (luty 1995): 37–53. http://dx.doi.org/10.1016/s1047-9651(18)30477-7.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

O’Rourke, Robert A., Kanu Chatterjee i Jeanne Y. Wei. "Coronary heart disease". Journal of the American College of Cardiology 10, nr 2 (sierpień 1987): 52A—56A. http://dx.doi.org/10.1016/s0735-1097(87)80449-7.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Friesinger, Gottlieb C., i Thomas J. Ryan. "CORONARY HEART DISEASE". Cardiology Clinics 17, nr 1 (luty 1999): 93–122. http://dx.doi.org/10.1016/s0733-8651(05)70059-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Bishop, Tina. "Coronary heart disease". Primary Health Care 26, nr 5 (26.05.2016): 14. http://dx.doi.org/10.7748/phc.26.5.14.s18.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Cook, Rosemary. "Coronary heart disease". Primary Health Care 6, nr 6 (czerwiec 1988): 25–30. http://dx.doi.org/10.7748/phc.6.6.23.s11.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Robinson, Karen. "Coronary heart disease". Emergency Nurse 9, nr 7 (listopad 2001): 29–34. http://dx.doi.org/10.7748/en2001.11.9.7.29.c1376.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Augustin, Joi, i Johanna Dwyer. "Coronary heart disease". Topics in Clinical Nutrition 10, nr 1 (grudzień 1994): 1–13. http://dx.doi.org/10.1097/00008486-199410010-00003.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

&NA;. "CORONARY HEART DISEASE". Nursing 19, nr 1 (styczeń 1989): 97–99. http://dx.doi.org/10.1097/00152193-198901000-00031.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Tunstall-Pedoe, H. "Coronary heart disease." BMJ 303, nr 6804 (21.09.1991): 701–4. http://dx.doi.org/10.1136/bmj.303.6804.701.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

McMurray, J., i H. J. Dargie. "Coronary heart disease." BMJ 303, nr 6816 (14.12.1991): 1546–47. http://dx.doi.org/10.1136/bmj.303.6816.1546-a.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Poole-Wilson, P. A., i G. Sutton. "Coronary heart disease." BMJ 304, nr 6825 (22.02.1992): 504–5. http://dx.doi.org/10.1136/bmj.304.6825.504-b.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Davies, M. J. "CORONARY DISEASE: The pathophysiology of acute coronary syndromes". Heart 83, nr 3 (1.03.2000): 361–66. http://dx.doi.org/10.1136/heart.83.3.361.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Gershlick, A. H. "CORONARY DISEASE: Role of stenting in coronary revascularisation". Heart 86, nr 1 (1.07.2001): 104–12. http://dx.doi.org/10.1136/heart.86.1.104.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

JURGENSEN, J. S. "Severe aneurysmal coronary artery disease". Heart 86, nr 4 (1.10.2001): 404. http://dx.doi.org/10.1136/heart.86.4.404.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Fox, K. A. A. "CORONARY DISEASE: Acute coronary syndromes: presentation---clinical spectrum and management". Heart 84, nr 1 (1.07.2000): 93. http://dx.doi.org/10.1136/heart.84.1.93.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Rahman, M., A. Sumin i A. Ankudinov. "СОСТОЯНИЕ КОРОНАРНОГО РУСЛА ПРИ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА У ПАЦИЕНТОВ С ГИПОТИРЕОЗОМ". Baikal Medical Journal 2, nr 4 (25.12.2023): 64–71. http://dx.doi.org/10.57256/2949-0715-2023-4-64-71.

Pełny tekst źródła

Streszczenie:

Hypothyroidism is a significant aggravating factor for coronary heart disease (CHD). However, there are no practical recommendations for the management of this group to date. The main method of assessing the severity of coronary artery disease is a morphological assessment of the condition of the coronary arteries. The aim. To carry out comparative assessment of clinical parameters, including the state of the coronary bed in patients with coronary artery disease with newly diagnosed (without hormone replacement therapy) and primary manifest hypothyroidism compared with patients with coronary artery disease without hypothyroidism. Materials and methods. Two hundred and forty patients with CHD were examined. The study group included 90 patients with coronary heart disease and hypothyroidism, the comparison group consisted of 150 patients with coronary artery disease without thyroid pathology. A comprehensive examination of patients, including coronary angiography, was performed. The frequency of cases and characteristics of lesions of the coronary bed, the volume of interventions were assessed. The analysis of the obtained data was carried out in Statistica 10.0 (StatSoft Inc., USA). Results. In the study group (CHD and hypothyroidism), a statistically significantly increased level of myoglobin, a change in lipid profile parameters in relation to patients with CHD without hypothyroidism was found. In the group of patients with coronary artery disease and hypothyroidism, a predominance of the frequency of multivessel lesions of the coronary bed was revealed. The volume of surgical interventions between the examined patients did not reveal significant differences. Conclusion. Patients with coronary heart disease and hypothyroidism should be considered as a group of additional cardiovascular risk and require a more careful approach. It is possible to prescribe higher dosages of statins.

Style APA, Harvard, Vancouver, ISO itp.

35

Yakovleva, L. N. "Stable coronary heart disease". Medicine of Ukraine, nr 4(230) (29.03.2019): 45–50. http://dx.doi.org/10.37987/1997-9894.2019.4(230).185661.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Lee, I.-Min, Ralph S. Paffenbarger i Paul D. Thompson. "Preventing Coronary Heart Disease". Physician and Sportsmedicine 29, nr 2 (luty 2001): 37–52. http://dx.doi.org/10.3810/psm.2001.02.366.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Omenn, Gilbert S., Shirley A. A. Beresford i Arno G. Motulsky. "Preventing Coronary Heart Disease". Circulation 97, nr 5 (10.02.1998): 421–24. http://dx.doi.org/10.1161/01.cir.97.5.421.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Jairath, N., i Anne Woods. "Managing coronary heart disease". Dimensions of Critical Care Nursing 18, nr 5 (wrzesień 1999): 54. http://dx.doi.org/10.1097/00003465-199909000-00016.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Jackson, Rod, John Lynch i Sam Harper. "Preventing coronary heart disease". BMJ 332, nr 7542 (16.03.2006): 617–18. http://dx.doi.org/10.1136/bmj.332.7542.617.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

King, Kathryn M., i Heather M. Arthur. "Coronary Heart Disease Prevention". Journal of Cardiovascular Nursing 18, nr 4 (wrzesień 2003): 274–81. http://dx.doi.org/10.1097/00005082-200309000-00006.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Hayman, Laura L., i Patricia R. Reineke. "Preventing Coronary Heart Disease". Journal of Cardiovascular Nursing 18, nr 4 (wrzesień 2003): 294–301. http://dx.doi.org/10.1097/00005082-200309000-00008.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Ockene, I. S., i J. K. Ockene. "Preventing coronary heart disease". Tobacco Control 2, nr 2 (1.06.1993): 165. http://dx.doi.org/10.1136/tc.2.2.165b.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Assaf, Annlouise R., Kate L. Lapane, Joyce L. McKenney, Sonja McKinlay i Richard A. Carleton. "Coronary heart disease surveillance". Journal of Clinical Epidemiology 53, nr 4 (kwiecień 2000): 419–26. http://dx.doi.org/10.1016/s0895-4356(99)00183-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Thompson, GilbertR, Rossitza Naoumova, Paul Sidhu, Richard Underwood, PaulD Flynn, CarolA Seymour, DerekG Cook, F. Game i R. Neary. "Predicting coronary heart disease". Lancet 343, nr 8898 (marzec 1994): 670–72. http://dx.doi.org/10.1016/s0140-6736(94)92664-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Rose, Geoffrey, M. P. H. Doublet Stewart, ChristopherA Birt, PeterR Croft i PatrickF James. "CORONARY HEART DISEASE PREVENTION". Lancet 332, nr 8619 (listopad 1988): 1081–82. http://dx.doi.org/10.1016/s0140-6736(88)90102-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Mccormick, JamesS, Petr Skrabanek, J. A. Lee i R. C. Cottrell. "CORONARY HEART DISEASE PREVENTION". Lancet 332, nr 8621 (listopad 1988): 1189–90. http://dx.doi.org/10.1016/s0140-6736(88)90252-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Henderson, Andrew. "Coronary heart disease: Overview". Lancet 348 (listopad 1996): S1—S4. http://dx.doi.org/10.1016/s0140-6736(96)98001-0.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Messerli, Franz H. "Ephemeral Coronary Heart Disease". European Heart Journal 40, nr 24 (21.06.2019): 1906–8. http://dx.doi.org/10.1093/eurheartj/ehz400.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Linden, B. "Coronary heart disease prevention". Coronary Health Care 3, nr 2 (maj 1999): 99–104. http://dx.doi.org/10.1016/s1362-3265(99)80022-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Linden, Belinda. "Coronary heart disease prevention". Coronary Health Care 3, nr 1 (luty 1999): 48–53. http://dx.doi.org/10.1016/s1362-3265(99)80034-0.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!